NYSE - Delayed Quote • USD
At close: June 6 at 4:00 PM EDT
Line
Candle
Baseline
Mountain
Bar
Loading Chart for LH
9/21 12:03 PM
DELL
Date | |
Close | |
Open | |
High | |
Low | |
Volume |
- Previous Close
198.00 - Open
196.94 - Bid --
- Ask 309.61 x 1000
- Day's Range
196.52 - 199.71 - 52 Week Range
186.40 - 234.09 - Volume
412,628 - Avg. Volume
768,449 - Market Cap (intraday)
16.725B - Beta (5Y Monthly) 1.03
- PE Ratio (TTM)
42.40 - EPS (TTM)
4.68 - Earnings Date Jul 25, 2024 - Jul 29, 2024
- Forward Dividend & Yield 2.88 (1.45%)
- Ex-Dividend Date May 28, 2024
- 1y Target Est
239.14
Labcorp Holdings Inc. operates as a laboratory services company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers.
67,000
Full Time Employees
December 31
Fiscal Year Ends
Healthcare
Sector
Industry
More about Labcorp Holdings Inc.
Recent News: LH
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview: LH
Trailing total returns as of 6/6/2024, which may include dividends or other distributions. Benchmark is
YTD Return
LH
12.10%
S&P 500
12.23%
1-Year Return
LH
7.51%
S&P 500
25.25%
3-Year Return
LH
10.78%
S&P 500
26.55%
5-Year Return
LH
42.44%
S&P 500
89.41%
Compare To: LH
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
198.41
+0.21%
Mkt Cap 16.725B
Industry Diagnostics & Research
142.64
-0.04%
Mkt Cap 15.846B
Industry Diagnostics & Research
221.62
+2.54%
Mkt Cap 11.416B
Industry Diagnostics & Research
111.02
+1.06%
Mkt Cap 13.699B
Industry Diagnostics & Research
322.02
-2.31%
Mkt Cap 26.626B
Industry Diagnostics & Research
0.0004
0.00%
Mkt Cap 114,597
Industry Diagnostics & Research
220.49
+0.73%
Mkt Cap 40.173B
Industry Diagnostics & Research
109.22
-1.42%
Mkt Cap 13.413B
Industry Diagnostics & Research
579.84
+0.79%
Mkt Cap 221.334B
Industry Diagnostics & Research
44.93
+0.67%
Mkt Cap 9.968B
Industry Diagnostics & Research
267.98
+0.05%
Mkt Cap 198.489B
Industry Diagnostics & Research
Statistics: LH
Valuation Measures
As of 6/6/2024
Market Cap
16.72B
Enterprise Value
22.59B
Trailing P/E
42.40
Forward P/E
13.37
PEG Ratio (5yr expected)
0.47
Price/Sales (ttm)
1.40
Price/Book (mrq)
2.10
Enterprise Value/Revenue
1.84
Enterprise Value/EBITDA
16.38
Financial Highlights
Profitability and Income Statement
Profit Margin
3.52%
Return on Assets (ttm)
3.76%
Return on Equity (ttm)
4.37%
Revenue (ttm)
12.3B
Net Income Avi to Common (ttm)
399.2M
Diluted EPS (ttm)
4.68
Balance Sheet and Cash Flow
Total Cash (mrq)
99.3M
Total Debt/Equity (mrq)
75.83%
Levered Free Cash Flow (ttm)
1.05B
Research Analysis: LH
Company Insights: LH
Research Reports: LH
People Also Watch
DGX Quest Diagnostics Incorporated
142.64
-0.04%
WAT Waters Corporation
300.55
-2.16%
UHS Universal Health Services, Inc.
189.34
-0.07%
HOLX Hologic, Inc.
74.78
+0.71%
HUM Humana Inc.
355.43
-1.54%
MCK McKesson Corporation
586.11
+1.12%
HSIC Henry Schein, Inc.
68.60
-1.49%
IQV IQVIA Holdings Inc.
220.49
+0.73%
DVA DaVita Inc.
143.84
-0.82%
HCA HCA Healthcare, Inc.
336.82
-0.03%
MTD Mettler-Toledo International Inc.
1,438.03
-0.96%
XRAY DENTSPLY SIRONA Inc.
27.78
+0.51%
COO The Cooper Companies, Inc.
95.25
+1.08%
RMD ResMed Inc.
211.56
-0.79%
ZBH Zimmer Biomet Holdings, Inc.
113.37
+0.65%
BDX Becton, Dickinson and Company
240.17
+1.64%